Hypothyroidism

Populations and Risk Factors

• Adult females are approximately 5–8 times more likely to be affected than males; prevalence increases with age, affecting up to 10–15% of women over 60
• Strong association with other autoimmune conditions: type 1 diabetes, rheumatoid arthritis, pernicious anemia, vitiligo, celiac disease — Hashimoto's often clusters with these
• Occurs as a congenital condition in newborns (cretinism), causing irreversible intellectual disability and stunted bone growth if untreated within the first weeks of life
• Often develops following thyroidectomy or radioactive iodine therapy for hyperthyroidism or thyroid cancer — these patients are iatrogenically hypothyroid and on lifelong replacement
• Medications including lithium, amiodarone, and interferon-alpha can induce hypothyroidism
• Radiation to the head and neck increases risk
• Family history of thyroid disease increases risk 2–3 fold
• Postpartum thyroiditis affects 5–10% of women within the first year after delivery; most cases are transient but some progress to permanent hypothyroidism

Causes and Pathophysiology

The Hypothalamic-Pituitary-Thyroid Axis

• The hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the anterior pituitary to release thyroid-stimulating hormone (TSH). TSH then stimulates the thyroid gland to produce T4 (thyroxine, the storage form) and T3 (triiodothyronine, the active form).
• T4 is converted to T3 in peripheral tissues (liver, kidneys, muscle) by deiodinase enzymes. T3 is 3–5 times more biologically active than T4 and is the hormone that actually acts on target cells.
• When circulating T3/T4 levels drop, the pituitary compensates by increasing TSH — this is why primary hypothyroidism shows elevated TSH with low T3/T4. The elevated TSH is the most sensitive early marker.
• In secondary hypothyroidism (pituitary failure) or tertiary hypothyroidism (hypothalamic failure), TSH is low or inappropriately normal despite low T3/T4 — these are much rarer.

Hashimoto Thyroiditis — Autoimmune Destruction

• T-lymphocyte and antibody-mediated destruction of thyroid follicular cells progressively reduces the gland's capacity to produce hormones. Anti-thyroid peroxidase (anti-TPO) antibodies are present in 90–95% of cases.
• The destruction is gradual — patients may spend years in a subclinical phase (elevated TSH, normal T3/T4) before clinical symptoms emerge. The gland may initially enlarge (goiter) as remaining tissue compensates, then atrophy as destruction becomes near-total.
• The autoimmune process can fluctuate, producing intermittent periods of thyroid hormone release from damaged follicles (hashitoxicosis) that transiently mimic hyperthyroidism before settling into permanent hypothyroidism.

Why Myxedema Develops — The Mucopolysaccharide Mechanism

• Thyroid hormones normally stimulate fibroblasts to degrade glycosaminoglycans (GAGs) — specifically hyaluronic acid and chondroitin sulfate — in the extracellular matrix. When T3/T4 are deficient, GAG degradation slows while production continues.
• These hydrophilic mucopolysaccharides accumulate in the dermis, subcutaneous tissues, and organ interstitial spaces. They bind water osmotically, producing a distinctive boggy, doughy tissue swelling that does not pit on pressure (unlike protein-poor edema in CHF or lymphedema).
• Myxedema is most visible in the face (periorbital puffiness, swollen lips) and hands but is present throughout the body. In severe cases, mucopolysaccharide deposits in the pericardium, pleural space, and synovial membranes cause pericardial effusion, pleural effusion, and joint effusion.
• Clinical distinction from other edema: Myxedema is non-pitting because the accumulated mucopolysaccharides form a gel-like matrix that resists displacement. Lymphedema initially pits but becomes non-pitting as fibrosis develops. CHF edema pits readily and is gravity-dependent. This distinction is critical for massage therapists assessing tissue swelling.

Why Myalgia and Muscle Stiffness Develop

• Thyroid hormones regulate muscle fiber metabolism, specifically the rate of calcium reuptake by the sarcoplasmic reticulum and the activity of myosin ATPase. When T3 is deficient, calcium reuptake slows — muscles contract and relax more slowly, producing the characteristic stiffness, achiness, and cramping.
• The slowed calcium reuptake also explains the "hung-up" deep tendon reflex — the reflex contraction occurs normally, but the relaxation phase is visibly prolonged (the reflex hammer strikes, the muscle contracts, and then slowly, almost reluctantly, returns to its resting state). This is pathognomonic for hypothyroidism and should be distinguished from the brisk, hyperreflexic response of UMN lesions.
• Mucopolysaccharide infiltration of muscle tissue (myxedema of muscle) further contributes to stiffness, weakness, and a sensation of heaviness. Creatine kinase (CK) levels may be mildly elevated due to increased membrane permeability — this is not rhabdomyolysis and does not require emergent intervention.
• Generalized myalgia affects 30–80% of hypothyroid patients. The pain is diffuse, aching, often worse with cold exposure, and frequently misdiagnosed as fibromyalgia before the thyroid condition is identified.

Why Carpal Tunnel Syndrome Develops — Median Nerve Myxedema Compression

• Mucopolysaccharide accumulation within the carpal tunnel increases the volume of contents within the rigid osteoligamentous canal. The median nerve, being the most compressible structure in the tunnel, is compressed against the transverse carpal ligament.
• This mechanism produces CTS in approximately 30% of hypothyroid patients — a much higher prevalence than the general population (3–6%). The CTS is bilateral in most cases (reflecting the systemic nature of myxedema) and often resolves or significantly improves with thyroid hormone replacement alone, without surgical intervention.
• Clinically, hypothyroid CTS presents identically to mechanical CTS: nocturnal paresthesias in the median nerve distribution (thumb, index, middle finger, radial half of ring finger), thenar weakness in advanced cases, positive Phalen's and Tinel's tests. The distinguishing clue is bilateral presentation with other hypothyroid features.

Why Cold Intolerance Develops

• Thyroid hormones are the primary regulators of basal metabolic rate (BMR) and the calorigenic effect (heat production from metabolism). T3 stimulates mitochondrial oxygen consumption and uncoupling protein activity — the mechanisms that generate body heat.
• When T3 is deficient, BMR drops 30–40%, and heat production falls proportionally. Peripheral vasoconstriction develops as a compensatory mechanism to conserve core body temperature, producing cold extremities.
• Cold intolerance is one of the earliest and most consistent symptoms — patients report feeling cold when others are comfortable, needing extra layers, and intolerance of air-conditioned environments.

Cardiovascular Consequences

• Hypothyroidism increases LDL cholesterol and total cholesterol by reducing hepatic LDL receptor expression, accelerating atherosclerosis. Bradycardia develops from reduced cardiac chronotropic response.
• Diastolic hypertension is common (increased systemic vascular resistance from peripheral vasoconstriction with reduced cardiac output).
• Pericardial effusion from mucopolysaccharide accumulation can occur in severe cases — usually asymptomatic but detectable on echocardiography.

Signs and Symptoms

Metabolic and General

• Unintended weight gain (5–15 kg) from reduced BMR and fluid retention, despite unchanged caloric intake
• Profound fatigue and lethargy that does not improve with rest — this is metabolic fatigue, not deconditioning alone
• Cold intolerance — feeling cold when others are comfortable; cold extremities
• Chronic constipation from slowed GI motility
• Hoarse voice from mucopolysaccharide infiltration of the vocal cords

Dermatologic

• Dry, rough, coarse skin with a yellowish tinge (carotenemia from impaired vitamin A conversion)
• Coarse, brittle hair; loss of the lateral third of the eyebrows (a specific clinical marker)
• Brittle nails
• Myxedema — non-pitting, boggy, doughy swelling of the face (periorbital puffiness, swollen lips), hands, and feet

Neuromuscular — The MT-Relevant Cluster

• Generalized myalgia — diffuse, aching muscle pain, often worse with cold exposure; frequently misdiagnosed as fibromyalgia
• Muscle stiffness — most prominent in the morning and after periods of inactivity; slow to warm up; muscles feel heavy and wooden
• Delayed deep tendon reflexes — the "hung-up" reflex: contraction phase is normal but relaxation phase is visibly prolonged
• Muscle weakness — generalized but particularly affecting proximal muscles; grip strength may be reduced
• Muscle cramping — especially in calves and feet, often nocturnal
• Carpal tunnel syndrome — bilateral nocturnal paresthesias in the median nerve distribution; 30% prevalence
• Joint stiffness and effusions — from mucopolysaccharide infiltration of synovial membranes

Neuropsychiatric

• Cognitive slowing ("brain fog"), poor concentration, memory impairment
• Depression — hypothyroidism should be ruled out in any new presentation of depression
• Bradycardia (resting heart rate 50–60 bpm or lower)

Emergency Presentation — Myxedema Coma

• Extreme hypothermia (core temperature may drop below 35degC), cardiovascular collapse (severe bradycardia, hypotension), altered consciousness progressing to coma → this is a medical emergency with 20–40% mortality; do not treat; call emergency services immediately

Assessment Profile

Subjective Presentation

• Chief complaint: Client typically presents for generalized muscle aches and stiffness ("my whole body feels heavy and sore"), fatigue, or hand numbness. Many have a known diagnosis and are on levothyroxine; some present with undiagnosed hypothyroidism and describe a gradual onset of "everything slowing down." Cold hands and feet are a frequent secondary complaint.
• Pain quality: Diffuse, deep aching muscle pain — worse with cold exposure and prolonged inactivity; not sharp or lancinating unless CTS nerve compression is producing paresthesias (burning, tingling in the median nerve distribution). Muscle cramping may be described, particularly nocturnal calf cramps.
• Onset: Insidious — symptoms develop over months to years. Muscle stiffness and fatigue typically precede the CTS symptoms. Post-thyroidectomy or post-radioactive iodine patients may have a more defined onset timeline.
• Aggravating factors: Cold environments worsen myalgia, stiffness, and cold intolerance; prolonged inactivity increases stiffness; sustained wrist flexion or gripping worsens CTS symptoms; mornings are typically worst ("I need an hour to loosen up").
• Easing factors: Warmth and gentle movement reduce stiffness; thyroid hormone replacement (levothyroxine) at therapeutic levels reduces all symptoms; wrist splinting at night eases CTS symptoms.
• Red flags: Signs of myxedema coma (extreme hypothermia, altered consciousness, severe bradycardia, respiratory depression) → emergency referral; do not treat. Rapidly worsening symptoms in a client who has stopped taking levothyroxine → medical referral. Unilateral CTS with thenar atrophy in a non-hypothyroid presentation → consider mechanical CTS or cervical radiculopathy rather than myxedema.

Observation

• Local inspection: Periorbital puffiness and facial swelling (myxedema facies); swollen hands and feet; dry, coarse, yellowish skin; loss of lateral third of eyebrows; hair thinning; tongue may appear enlarged (macroglossia from myxedema); inspect for goiter (anterior neck fullness). If no visible changes, state that explicitly — subclinical or well-managed patients may show minimal external signs.
• Posture: Rounded shoulder/forward head posture from fatigue and generalized deconditioning; may appear listless and move slowly; kyphotic tendency from muscle weakness and low energy. Posture reflects the systemic fatigue rather than a specific structural lesion.
• Gait: Slow, deliberate gait — reduced stride length from generalized stiffness and fatigue; may appear stiff on initial movement then improve with continued walking (the "loosening up" pattern). Not typically antalgic unless CTS or joint effusions produce specific guarding.

Palpation

• Tone: Generalized muscle stiffness with a heavy, doughy quality — muscles feel full and resistant to passive elongation but without the velocity-dependent resistance of UMN spasticity or the acute protective guarding of an injury. Upper trapezius and cervical paraspinals commonly hypertonic from postural fatigue. Proximal muscle groups (quadriceps, deltoids) may feel simultaneously stiff and weak — this paradox of stiffness-with-weakness is characteristic of hypothyroid myopathy and distinguishes it from mechanical muscle tightness.
• Tenderness: Diffuse muscular tenderness to moderate pressure — not localized to specific trigger points or anatomical landmarks. Tender points may overlap with fibromyalgia tender point locations, but hypothyroid myalgia responds to thyroid hormone replacement while fibromyalgia does not. Thenar eminence tenderness and Tinel's point tenderness at the wrist if CTS is present. Spinous process tenderness is not expected unless there is comorbid osteoporosis.
• Temperature: Cool extremities (hands and feet) bilaterally — reflects reduced peripheral perfusion from vasoconstriction and decreased BMR. Compare proximal to distal temperature gradient — a marked gradient suggests significant circulatory compromise. The body generally feels cool to the touch compared to a euthyroid individual.
• Tissue quality: Myxedematous tissue has a distinctive non-pitting, doughy, boggy quality — pressure produces a slow, incomplete rebound rather than the sharp pit-and-fill of CHF edema or the firm fibrotic feel of chronic lymphedema. Skin is dry, rough, and inelastic — may crack easily with friction or insufficient lubricant. Subcutaneous tissue feels thickened. Fascial mobility is reduced globally. If the therapist can recognize the myxedema texture, it is one of the most reliable palpatory findings for suspected undiagnosed hypothyroidism.

Motion Assessment

• AROM: Generalized reduction in ROM across all joints — not following a capsular or non-capsular pattern but reflecting global stiffness and deconditioning. Cervical ROM mildly restricted in all directions. Shoulder ROM reduced but without the capsular pattern of adhesive capsulitis (ER most restricted > Abd > IR). Wrist ROM may be limited by CTS pain and hand swelling. ROM characteristically improves with sustained gentle movement ("warms up" over the session).
• PROM / end-feel: End-feel is typically firm-elastic (muscle and connective tissue resistance from myxedematous infiltration) rather than capsular/leathery. PROM modestly exceeds AROM in most joints — the restriction is muscular/connective tissue, not capsular. This distinguishes hypothyroid stiffness from adhesive capsulitis or inflammatory arthritis.
• Resisted testing: Generalized mild weakness, particularly in proximal muscle groups (hip flexors, shoulder abductors, grip strength). Weakness is non-myotomal — does not follow a nerve root or peripheral nerve pattern. Pain on resisted testing is not expected unless the muscle is acutely cramping. The weakness-with-stiffness paradox is characteristic.

Special Test Cluster

Conditional cluster — if CTS symptoms are bilateral with no mechanical risk factors: Add Spurling's test and ULTT2a (median nerve bias) to rule out cervical radiculopathy (C6–C7) as the cause of hand paresthesias. Bilateral CTS in the context of other hypothyroid features strongly suggests myxedema compression; unilateral CTS with dermatomal distribution warrants cervical investigation.

Differential Assessment